The comparison of islet β-cell function and insulin resistance between glucose-in-target-level therapy and routine therapy in patients with newly diagnosed type 2 diabetes

( views:161, downloads:0 )
Author:
LI Yu-lan(Department of Endocrinology, The Fifth Affiliated Hospital of Guangxi Medical University, Liuzhou 545006, China)
HUANG Zhen-yu(Department of Endocrinology, The Fifth Affiliated Hospital of Guangxi Medical University, Liuzhou 545006, China)
XIAO Li-hang(Department of Endocrinology, The Fifth Affiliated Hospital of Guangxi Medical University, Liuzhou 545006, China)
()
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
Volume 18, Issue 1, 2010
DOI:
10.3969/j.issn.1006-6187.2010.01.002
Key Word:
Diabetes mellitus,type 2;Islet β-cell function; Insulin resistance

Abstract:

  • [1]李延兵,翁建平.保护β细胞功能以改善2型糖尿病的自然病程.国外医学内分泌学分册,2005,25:181-183.
  • [2]叶新华,杜云峰,高剑波,等.短期诺和锐强化治疗对初诊2型糖尿病患者胰岛β细胞功能的影响.中华糖尿病杂志,2005,13:114-117.
  • [3]Bermudez-Pirela VJ,Cano C,Medina MT,et al.Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA (IR)) and beta-cell function(HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.American journal of therapeutics,2007,14:194-202.
  • [4]蔡明江,张南雁,成杰,等.新诊断2璎糖尿病胰岛素强化治疗与常规治疗的对比研究.中国现代医学杂志,2004,14:72-75.
  • [5]Weir GC,Bonner WS.Five stage of evolving Beta-cell dysfunctionduring progression to diabetes.Diabetes,2004,53:S16-S21.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn